% Expired Patents = 100.0

EPO Patents = 2

Trademarks = 5

Forward Citations = 3

Loading Chart...

9 inventors (with patents filed for the assignee):

Dong-Ki Choi (3 out of 3 patents)

Yong-Sung Kim (2 out of 11 patents)

Sung-Hoon Kim (2 out of 157 patents)

4. Seung-Min Shin (2 out of 11 patents)

5. Ji Sun Kim (2 out of 32 patents)

6. Yong Sung Kim (2 out of 28 patents)

7. Jae Yeong Park (2 out of 2 patents)

8. Seong Wook Park (1 out of 1 patent)

9. Sei Yong Jun (1 out of 1 patent)

10. Dong Ki Choi (4 patents)

11. Sung Hoon Kim (102 patents)

12. Seung Min Shin (0 patent)

4 patents: Sort by Forward Citations

1. 11155641 - Cytosol-penetrating antibody and use thereof (2021-10-26),

2. 10851177 - Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereof (2020-12-01),

3. 10844136 - Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same (2020-11-24),

4. 10787487 - Cell/tissue-specific cell-penetrating antibodies (2020-09-29),

Orum Therapeutics Inc. is a biotechnology company focused on developing novel protein therapeutics for cancer and other diseases. Their proprietary technology platform enables the design of small proteins that can target intracellular protein-protein interactions, which are traditionally difficult to drug. Orum Therapeutics is dedicated to advancing breakthrough therapies through their innovative approach.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

4 Patents

#114 in Daejeon

#2,193 in South Korea

Daejeon, South Korea

Orum Therapeutics Inc.